Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 3/20 | 0.43 |
| ▸ | BCHE | P06276 | 3/20 | 0.42 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Afalanine SCHEMBL5154381 | 0.82 | ITGB3 (0.46) | DRD2FAAHGPR34 | |
| SCHEMBL14825246 | 0.81 | FAAH (0.51) | FAAHBCHE | |
| SCHEMBL8583410 | 0.81 | FAAH (0.53) | DRD2ALDH1A1FAAH | |
| SCHEMBL5154387 | 0.80 | FAAH (0.41) | DRD2ALDH1A1FAAHBCHE | |
| SCHEMBL14825242 | 0.79 | FAAH (0.47) | DRD2ALDH1A1FAAHBCHE | |
| SCHEMBL9533373 | 0.79 | BCHE (0.52) | DRD2FAAHBCHE | |
| Phenylalanine SCHEMBL5154392 | 0.78 | FAAH (0.49) | FAAH | |
| Bepotastine SCHEMBL29459 | 0.77 | BCHE (0.55) | DRD2FAAHBCHEDRD4 | |
| Bepotastine SCHEMBL726880 | 0.77 | BCHE (0.55) | DRD2FAAHBCHEDRD4 | |
| Bepotastine SCHEMBL30200949 | 0.77 | BCHE (0.55) | DRD2FAAHBCHEDRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020026054-A1 | Acid addition salt of optically active piperidine compound and process for preparing the same | UBE INDUSTRIES, LTD. | 2002-02-28 | — | — | US | disclosed |
| US-6307052-B1 | Acid-addition salts of optically active piperidine compound and process for producing the same | UBE INDUSTRIES, LTD. (JP) | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020026054-A1 | Acid addition salt of optically active piperidine compound and process for preparing the same | CMA1, HRH1, HRH2 | DRD2 1620/4885ALDH1A1 282/4885FAAH 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.